The burden of healthcare costs associated with prostate cancer in Ireland
PurposeWith one of the highest incidences across Europe and the rest of the World in 2012, the Republic of Ireland (RoI) has experienced significant increases in prostate cancer (PCa) since 1994. The main driver is the widespread use of PSA testing which is used to detect PCa. This is expected to ha...
Main Authors: | Richéal M. Burns, Jose Leal, Jane Wolstenholme, Ciaran O’Neill, Frank J. Sullivan, Frances J. Drummond, Linda Sharp |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2016-12-01
|
Series: | Global & Regional Health Technology Assessment |
Online Access: | http://www.grhta.com/Attach/D2C3CB15-CC4B-43AF-B15B-ABA4BAF7821D/48AA4727-1274-474B-B76C-44E8F772C62A |
Similar Items
-
The burden of healthcare costs associated with prostate cancer in Ireland
by: Burns, R, et al.
Published: (2016) -
Unit costs for non-acute care in Ireland 2016—2019 [version 1; peer review: 2 approved]
by: Samantha Smith, et al.
Published: (2021-04-01) -
Are we there yet? Closing the gap of prostate cancer presentation disparities in Ireland
by: Noa Gordon, et al.
Published: (2024-11-01) -
Assessing the impact on inequalities in use of orthodontic services of the introduction of an objective measure of treatment need in Northern Ireland
by: Kishan Patel, et al.
Published: (2019-11-01) -
A pilot study of the duration of GP consultations in Ireland
by: Tom Pierse, et al.
Published: (2019-12-01)